TFDA confirms discolored Adimmune flu vaccine as 'isolated incident'

The Taiwan Food and Drug Administration (TFDA) confirmed on Wednesday the previous conclusion of the Centers for Disease Control (CDC) that a discolored dose of Adimmune Corp.'s influenza vaccine reported in October was an "isolated incident."

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)